You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Tag, Track, and Locate (TTL) technologies and concepts for combating weapons of mass destruction (CWMD).

    SBC: SURFACE TREATMENT TECHNOLOGIES, INC.            Topic: DTRA10001

    To address the needs of the Defense Threat Reduction Agency (DTRA), GSI will perform in three areas during the course of this effort. 1) GSI will evaluate a new formulation, capable of self-propagating reaction with the production of an electrically conductive aerosol, for the purpose of Intrusive Electronic Equipment Defeat. This material will be evaluated against electronic equipment (PC's) and ...

    SBIR Phase II 2015 Department of DefenseDefense Threat Reduction Agency
  2. Enhancing Augmentative and Alternative Communication Speed and Accuracy

    SBC: Speak Agent, Inc.            Topic: edIES15R0008

    Video Demonstration of the Phase I Prototype: http://youtu.be/0FtoN0AX6PE Purpose: This project team will develop and test an app, Speak Agent AAC, intended to increase communication rates and provide individualized supports to students with speech disabilities who use assistive technology to communicate. Among school-aged children with speech communication disabilities, students with Autism Spec ...

    SBIR Phase II 2015 Department of Education
  3. IGF OT IGF SMART FUSION HIGH AFFINITY PEPTIDE CAPTURE REAGENTS

    SBC: A&G PHARMACEUTICAL, INC.            Topic: NCI

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  4. IGF OT IGF HIGH AFFINITY SISCAPA ANTIBODIES

    SBC: ORIGENE TECHNOLOGIES, INC.            Topic: NCI

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  5. IGF OT IGF CLINICAL DEVELOPMENT OF IPDR FOR RADIOSENSITIZATION

    SBC: Shuttle Pharmaceuticals, Inc.            Topic: NCI

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  6. IGF OT IGF MOBILE APPLICATION FOR PRESCRIPTION DRUG ABUSE EDUCATION MAPDE N DA PURPOSE TO EXERCISE OPTION PERIOD CONTRACT YEAR

    SBC: SICORE TECHNOLOGIES INC.            Topic: NIDA

    The proposed Phase II effort shall Prepare the MAPDE application for use in primary care settings and long term use by patients for the purpose of prescription misuse risk reduction Develop the protocol and attain approvals for a pilot study to evaluate MAPDE over standard care in reducing risk of misuse and abuse To conduct a pilot study and analyze the results for misuse risk measures and fi ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  7. IGF OT IGF ACA WEB PLATFORM TO INTEGRATE BEHAVIORAL HEALTH AND PREVENTION WITH PRIMARY CARE PERIOD OF PERFORMANCE BASE AWARD

    SBC: Medical Decision Logic, Inc.            Topic: NIDA

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  8. Infant Screening of Early Communication Risk: The CISS, Phase II

    SBC: PAUL H BROOKES PUBLISHING CO., INC.            Topic: Y

    DESCRIPTIONprovided by applicantEffective early intervention depends on reliable screening of risk for communication impairments as soon as possibleEstablished infant communication risk factors include poor attentiongesturessocial connectednessexploratory playand speechAlthough these risk factors can be detected bymosand reliably predict later language and social disordersattempts to detect simila ...

    STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  9. Late-stage development toward commercialization of multilineage point-of-care Lassa fever diagnostics

    SBC: Zalgen Labs            Topic: NIAID

    DESCRIPTION provided by applicant This project will complete development efforts toward commercialization of multilineage point of care Lassa fever diagnostics Lassa fever LF is a severe often fatal viral hemorrhagic fever VHF Because of its high case fatality rate ability o spread easily by human human contact and potential for aerosol release Lassa virus LASV the causative agent ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  10. Optimization of a Therapeutic HIVSIV Multi Antigen DNA Vaccine

    SBC: PROFECTUS BIOSCIENCES, INC.            Topic: R

    DESCRIPTION The HIV pandemic is one of the greatest public health challenges in history It is estimated that million people are living with HIV and million of those are newly infected In a number of developed countries the risk of death associated with HIV infection has sharply declined due to the use of highly active antiretroviral therapy HAART Unfortunately the rate of new HIV i ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government